Big data are coming to psychiatry: a general introduction
Big data are coming to the study of bipolar disorder and all of psychiatry. Data are coming
from providers and payers (including EMR, imaging, insurance claims and pharmacy data) …
from providers and payers (including EMR, imaging, insurance claims and pharmacy data) …
[HTML][HTML] “Big data” in the intensive care unit. Closing the data loop
LA Celi, RG Mark, DJ Stone… - American journal of …, 2013 - ncbi.nlm.nih.gov
The data generated in the process of medical care has historically not just been underused,
it has been wasted. This was due in part to the difficulty of accessing, organizing, and using …
it has been wasted. This was due in part to the difficulty of accessing, organizing, and using …
Multidrug Interactions: Why Do They Occur and How to Handle?
P Dow, V Michaud, J Turgeon - Clinical Therapeutics, 2023 - Elsevier
ABSTRACT A nonoptimized medication therapy (NOMT) event is an iatrogenic hazard or
incident associated with medications and is a leading cause of death, serious injury, and …
incident associated with medications and is a leading cause of death, serious injury, and …
[HTML][HTML] Making big data useful for health care: a summary of the inaugural mit critical data conference
With growing concerns that big data will only augment the problem of unreliable research,
the Laboratory of Computational Physiology at the Massachusetts Institute of Technology …
the Laboratory of Computational Physiology at the Massachusetts Institute of Technology …
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018
Background/Aims The US Food and Drug Administration outlines clinical studies as
postmarketing requirements and commitments to be fulfilled following approval of new drugs …
postmarketing requirements and commitments to be fulfilled following approval of new drugs …
Active pharmacovigilance in China: recent development and future perspectives
X Li, H Li, J Deng, F Zhu, Y Liu, W Chen, Z Yue… - European Journal of …, 2018 - Springer
Background The effectiveness of active pharmacovigilance depends on the specific
methods adopted and the work patterns put into place. Over the past few years, much …
methods adopted and the work patterns put into place. Over the past few years, much …
Leveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality
Background Observational studies have found an increased risk of adverse effects such as
hemorrhage, stroke, and increased mortality in patients taking selective serotonin reuptake …
hemorrhage, stroke, and increased mortality in patients taking selective serotonin reuptake …
“Big data” in the intensive care unit. Closing the data loop
L Anthony Celi, RG Mark, DJ Stone… - American journal of …, 2013 - atsjournals.org
The data generated in the process of medical care has historically not just been underused,
it has been wasted. This was due in part to the difficulty of accessing, organizing, and using …
it has been wasted. This was due in part to the difficulty of accessing, organizing, and using …
From pharmacovigilance to clinical care optimization
In order to ensure the continued, safe administration of pharmaceuticals, particularly those
agents that have been recently introduced into the market, there is a need for improved …
agents that have been recently introduced into the market, there is a need for improved …
Real-Life Active Surveillance of a Naphazoline/Hypromellose Fixed Combination's Safety Profile in Peruvian Population
H Contreras-Salinas… - Integrated Pharmacy …, 2021 - Taylor & Francis
Objective Identifying the adverse reactions and the possible risks associated with the use of
naphazoline 0.1%+ hypromellose 0.5%(NAPH), thereby evaluating its tolerability and safety …
naphazoline 0.1%+ hypromellose 0.5%(NAPH), thereby evaluating its tolerability and safety …